RGC
Regencell Bioscience Holdings Ltd (RGC)
Healthcare • NASDAQ • $29.28-6.96%
Key Fundamentals
- Symbol
- RGC
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $29.28
- Daily Change
- -6.96%
- Market Cap
- $14.48B
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $83.60
- 52W Low
- $6.16
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 1.87
About Regencell Bioscience Holdings Ltd
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Company websiteResearch RGC on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.